SCHEMBL2825657

SCHEMBL2825657

CN(C)C(=S)ON1C(=O)C2C3C=CC(C3)C2C1=O

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
TDP1 Q9NUW8 1/20 0.47
KDM4E B2RXH2 1/20 0.45
SMN1; SMN2 Q16637 5/20 0.41
PKM P14618 1/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
RAB9A P51151 2/20 0.40
HTT P42858 2/20 0.40
USP2 O75604 1/20 0.40
TSHR P16473 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
MAPK1 P28482 1/20 0.39
LMNA P02545 1/20 0.38
RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27421567 0.79 ALDH1A1 (0.45) ALDH1A1TDP1KDM4ESMN1; SMN2PKM
SCHEMBL1006031 0.77 ALDH1A1 (0.53) ALDH1A1TDP1KDM4ESMN1; SMN2PKM
SCHEMBL13700490 0.76 ALDH1A1 (0.57) ALDH1A1TDP1SMN1; SMN2PKMMEN1
SCHEMBL21987044 0.76 ALDH1A1 (0.57) ALDH1A1TDP1SMN1; SMN2PKMMEN1
SCHEMBL20919927 0.76 ALDH1A1 (0.57) ALDH1A1TDP1SMN1; SMN2PKMMEN1
SCHEMBL13327129 0.76 ALDH1A1 (0.52) ALDH1A1TDP1KDM4ESMN1; SMN2PKM
SCHEMBL15759448 0.76 ALDH1A1 (0.52) ALDH1A1TDP1KDM4ESMN1; SMN2PKM
SCHEMBL21987045 0.75 ALDH1A1 (0.55) ALDH1A1TDP1SMN1; SMN2PKMMEN1
SCHEMBL20919929 0.75 ALDH1A1 (0.55) ALDH1A1TDP1SMN1; SMN2PKMMEN1
SCHEMBL21987047 0.75 ALDH1A1 (0.55) ALDH1A1TDP1SMN1; SMN2PKMMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1828258-B1 N-SUBSTITUTED IMIDES AS POLYMERIZATION INITIATORS BASF SE (DE) 2010-06-30 EP disclosed
EP-1828258-B1 N-SUBSTITUTED IMIDES AS POLYMERIZATION INITIATORS BASF SE (DE) 2010-06-30 EP disclosed
US-7723399-B2 N-substituted imides as polymerization initiators CIBA SPECIALTY CHEMICALS CORPORATION (US) 2010-05-25 US disclosed
US-7723399-B2 N-substituted imides as polymerization initiators CIBA SPECIALTY CHEMICALS CORPORATION (US) 2010-05-25 US disclosed
US-7723399-B2 N-substituted imides as polymerization initiators CIBA SPECIALTY CHEMICALS CORPORATION (US) 2010-05-25 US disclosed
US-20080132600-A1 N-Substituted Imides As Polymerization Initiators CIBA SPECIALTY CHEMICALS CORP. 2008-06-05 US disclosed
US-20080132600-A1 N-Substituted Imides As Polymerization Initiators CIBA SPECIALTY CHEMICALS CORP. 2008-06-05 US disclosed
US-20080132600-A1 N-Substituted Imides As Polymerization Initiators CIBA SPECIALTY CHEMICALS CORP. 2008-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132600-A1 N-Substituted Imides As Polymerization Initiators NR1H3, SIGMAR1, NR1H2 ALDH1A1 2799/4885TDP1 4573/4885KDM4E 2875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.